BRD4 and neoplasm: Data from in vivo studies suggest that BRD4 inhibition can also induce a variety of important, albeit reversible, phenotypes, including alopecia, skin hyperplasia, and small intestinal stem cell deficiency.197 Furthermore, BET inhibitors also have therapeutic effects on non-tumor cells, raising concerns about collateral damage to healthy tissues from their usage as anticancer drugs.